| Bioactivity | Calmodulin-Dependent Protein Kinase II (290-309) acetate is a potent CaMK antagonist with an IC50 of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II[1]. | ||||||
| Invitro | Peptide 290 to 309 is found to be a potent calmodulin antagonist with an IC50 of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase. Neither truncation from the amino terminus (peptide 296-309) nor extension in the carboxyl-terminal direction (peptide 294-319) markedly affects calmodulin binding, whereas shortening the peptide from the carboxyl terminus (peptide 290-302) or from both ends (peptide 295-304) results in the elimination of this activity[1]. | ||||||
| Name | Calmodulin-Dependent Protein Kinase II(290-309) acetate | ||||||
| Shortening | LKKFNARRKLKGAILTTMLA | ||||||
| Formula | C105H189N31O26S | ||||||
| Molar Mass | 2333.88 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Calmodulin-Dependent Protein Kinase II(290-309) acetate
CAS: F: C105H189N31O26S W: 2333.88
Calmodulin-Dependent Protein Kinase II (290-309) acetate is a potent CaMK antagonist with an IC50 of 52 nM for inhibitio
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.